Opioid antagonists that promoted weight loss in rats had high affinity for the kappa-2B binding site, while non-weight-loss compounds did not.
Kappa-2B selectivityOnly opioid antagonists with kappa-2B affinity promoted weight loss; those without it didn't, despite similar overall opioid binding
What the researchers found
Weight-loss-promoting phenylpiperidine antagonists like LY255582 had high affinity for the kappa-2B binding site. Non-weight-loss compounds did not.
Why it matters
This identifies a specific opioid receptor subsite involved in appetite and weight control. Targeting this site could lead to new weight loss drugs.
How the study worked
Phenylpiperidine opioid antagonists were tested for receptor binding at multiple opioid binding sites and compared based on their weight loss efficacy in lean and obese Zucker rats.
What this study cannot tell us
Animal study with binding data. Kappa-2B subtype classification was debated and not universally accepted. Mechanism of weight loss not fully established.
How to read the evidence
Preliminary — animal binding and weight loss study. The kappa-2B subtype classification was debated in the field.
When this study was published
Published in 1993 (33 years ago). The opioid system's role in appetite regulation is now well-established, though receptor subtype classifications have evolved.
The bigger picture
Obesity is a global health crisis. Identifying that a specific opioid receptor subtype controls appetite and weight opens the door to targeted weight loss drugs that don't affect pain or mood.
Questions still open
- Could kappa-2B-selective drugs become practical weight loss medications?
- Is the kappa-2B site involved in food reward and eating behavior?
Common questions
How are opioids connected to weight?
Why does the receptor subtype matter?
Read the original research
Phenylpiperidine opioid antagonists that promote weight loss in rats have high affinity for the kappa 2B (enkephalin-sensitive) binding site.
Peptides, 14(1), 17-20
Citation
Rothman, R B; Xu, H; Char, G U; Kim, A; De Costa, B R; Rice, K C; Zimmerman, D M. (1993). Phenylpiperidine opioid antagonists that promote weight loss in rats have high affinity for the kappa 2B (enkephalin-sensitive) binding site.. Peptides, 14(1), 17-20.